ProCE Banner Activity

PACE-MDS: Luspatercept Associated With Hematologic Improvement, Transfusion Independence in Lower-Risk MDS

Slideset Download
Conference Coverage
Improvement in anemia and reduced transfusion burden sustained for up to 1 year.

Released: December 08, 2015

Expiration: December 06, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen